Drugs Made In America Acquisition Corporation.

DMAA·NASDAQ·$10.61Share Price as of 11/2·$358MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/14/26 10-KFY 202504/15/26 10-QQ3 ended 09/30/2511/18/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report10/21/26 8-KCurrent report09/14/26 8-KCurrent report07/20/26 8-KCurrent report05/05/26 8-KCurrent report05/01/26

Prospectuses and Registrations

424B4Prospectus01/29/25 POS AMPost-effective amendment01/22/25 POS AMPost-effective amendment01/14/25 S-1/ARegistration statement (amended)01/06/25 S-1/ARegistration statement (amended)12/09/24

Proxies

DEFR14ADefinitive proxy (revised)04/16/26 DEF 14ADefinitive proxy04/14/26 PRE 14APreliminary proxy03/27/26

Ownership

SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13G/ABeneficial ownership (amended)08/13/26 SC 13GBeneficial ownership06/26/26 SC 13GBeneficial ownership05/14/26

Other

42542510/21/26 42542509/14/26 42542507/20/26 42542505/05/26 NT 10-KLate filing notification (10-K)04/01/26